WILD TYPE ATTR AMYLOIDOSIS

Clinical trials for WILD TYPE ATTR AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new WILD TYPE ATTR AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for WILD TYPE ATTR AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope for rare nerve disease? early trial tests patisiran

Disease control Ongoing

This early-phase study tests the drug patisiran in 10 adults with a rare disease called wild-type ATTR amyloidosis that causes nerve damage. The goal is to see if patisiran can improve nerve function and quality of life over 24 months. Participants will have regular check-ups and…

Matched conditions: WILD TYPE ATTR AMYLOIDOSIS

Phase: EARLY_PHASE1 • Sponsor: Austin Neuromuscular Center • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

WILD TYPE ATTR AMYLOIDOSIS

Get alerted when new WILD TYPE ATTR AMYLOIDOSIS trials appear

New hope for rare nerve disease? early trial tests patisiran